Stock & Company Details
Beam Therapeutics Inc $BEAM
Price:
N/A
N/A
103M
$2.2B
52 Week High:
N/A
10 Day Average Volume:
N/A
-25.70
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
BEAM technical indicators
Latest Beam Therapeutics Inc (BEAM) indicator readings as of 2026-11-19.
BEAM's 14-day RSI is 36.0, in neutral territory. ADX reads 19.3, indicating a range-bound market rather than a trend. MACD (12, 26, 9) is -1.10, below the zero line.
Overview
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing.
Finance Bot
Ask your questions
Start by typing a question below.